Nonimmune Hydrops Fetalis
Registered users can also download a PDF or listen to a podcast of this Pearl.
Log in now, or create a free account to access bonus Pearls features.
Nonimmune hydrops fetalis (NIHF) is the presence of excessive fluid in two or more fetal compartments (skin edema, pleural effusion, pericardial effusion, or ascites), in the absence of red cell alloimmunization. NIHF accounts for 90% of hydrops fetalis cases and occurs in 1/1,700-1/3,000 pregnancies. The pathophysiologic fetal mechanisms resulting in hydrops, include increased hydrostatic capillary pressure (CHF and raised intrathoracic pressure), decreased plasma oncotic pressure (occurs in inborn errors of metabolism, GI disorders), obstruction of lymphatic flow (chromosomal abnormalities) and damage to peripheral capillary integrity (infection). A thorough antenatal or postnatal evaluation results in a diagnosis in approximately 85% of cases. Multiple anomalies/genetic disorders are the most common cause of NIHF (19-53%), followed by cardiovascular structural anomalies (8-20%). Other possible etiologies include lymphatic dysplasia, infection, pulmonary/thoracic anomalies, Twin-twin transfusion syndrome, placental chorioangioma, hematological & gastrointestinal conditions, genitourinary anomalies, and extra-thoracic tumors.
Diagnostic steps should be taken to investigate underlying etiologies for pregnancies with one or multiple fetal effusions. The diagnostic evaluation begins with taking medical, obstetrical and family history and evaluating for medication usage and other exposures. The maternal blood type, Rh(D) antigen status, CBC, hemoglobin electrophoresis, and carrier screening results should be reviewed. An indirect Coombs test should be performed to evaluate for circulating red blood cell antibodies. If MCV is < 80, testing for alpha thalassemia should be considered. Serologic testing for syphilis should be reviewed and repeated. The Kleihauer-Betke stain or flow cytometry to assess for fetomaternal hemorrhage is also indicated.
Additional detailed fetal sonography of the fetus(es) and placenta is necessary, including fetal echocardiography and middle cerebral artery Doppler studies to evaluate for anemia. Regardless of whether the fetus is structurally normal or abnormal, chromosomal microarray analysis with or without fetal karyotype is recommended, in addition to PCR testing for parvovirus, CMV and toxoplasmosis. Percutaneous umbilical cord sampling should be considered if MCA dopplers are elevated. If all testing is negative, whole exome or genome sequencing should be offered.
The prognosis depends on the underlying etiology, response to therapy if treatable, and the gestational age at detection and delivery. Aneuploidy can confer a poor prognosis. Neonatal survival is often less than 50%. Management may include pregnancy termination, therapeutic interventions when appropriate, and palliative and psychosocial care as needed. Antepartum surveillance is necessary to identify fetal deterioration. Polyhydramnios, preterm birth, and mirror syndrome are a few of the complications that arise in NIHF. The timing of the delivery is largely individualized. Mirror syndrome, an uncommon complication where the mother develops edema that “mirrors” that of the hydropic fetus, may be a variant of preeclampsia. A few case reports describe the resolution of mirror syndrome with treatment of the etiology of the nonimmune hydrops fetalis. In most cases, mirror syndrome necessitates delivery. These pregnancies should be delivered at a facility with the capability to stabilize and treat the underlying etiology of these critically ill newborns. Preterm delivery should be reserved for obstetrical indications such as preeclampsia or mirror syndrome, preterm labor or premature rupture of membranes, new or worsening NIHF.. 1
In cases of termination of pregnancies with no known etiology, fetal autopsy would be beneficial in understanding the cause further.
Further Reading:
Swearingen C, Colvin ZA, Leuthner SR. Nonimmune Hydrops Fetalis. Clin Perinatol. 2020 Mar;47(1):105-121. doi: 10.1016/j.clp.2019.10.001. Epub 2019 Oct 7. PMID: 32000919.
Society for Maternal-Fetal Medicine (SMFM); Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015 Feb;212(2):127-39. doi: 10.1016/j.ajog.2014.12.018. Epub 2014 Dec 31. PMID: 25557883
Initial approval January 2009; Revised January 2018. Reaffirmed July 2019. Revised July 2021. Revised March 2023. Revised November 2024. Revised July 2026.
********** Notice Regarding Use ************
The Society for Academic Specialists in General Obstetrics and Gynecology, Inc. (“SASGOG”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.
This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high-quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. SASGOG reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. SASGOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither SASGOG nor its respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
Copyright 2026 The Society for Academic Specialists in General Obstetrics and Gynecology, Inc. All rights reserved. No re-print, duplication or posting allowed without prior written consent.
Back to Search Results